Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.

By C. Morillo, A. Verma, S. Connolly, K. Kuck, G. Nair, J. Champagne, L. Sterns, H. Beresh, J. Healey, A. Natale. Journal of the American Medical Association (JAMA), 2014

649 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/a6991685252c9dc5b449a3a72ac59050ffeebae7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Rahul Wadke
2. Stanley Nattel
3. Gerhard Hindricks

Citations in the corpus

• 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017, methodology): “STAR AF 2, Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination (ADVICE), FIRE AND ICE, and TOCCASTAR are just a few examples of multicenter randomized studies that have included hundreds of patients per study and added important contributions to the daily practice o”
• Atrial fibrillation. (2022, background): “However, recurrence of atrial fibrillation, immediately after the procedure or several years later is relatively common.(37,65)”